---
title: "Amgen Boasts Success In Sjogren's; Shares Charge Ahead"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299788700.md"
description: "On Tuesday, Amgen's stock showed upward movement above its 50-day line following the release of positive results for its experimental treatment for Sjogren's syndrome. The company's success in this treatment contributed to its stock rising, with shares showing progress. The news highlights Amgen's promising developments in the medical field."
datetime: "2026-09-22T15:04:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299788700.md)
  - [en](https://longbridge.com/en/news/299788700.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299788700.md)
generator: "portal-rs"
---

# Amgen Boasts Success In Sjogren's; Shares Charge Ahead

On Tuesday, Amgen's stock showed upward movement above its 50-day line following the release of positive results for its experimental treatment for Sjogren's syndrome. The company's success in this treatment contributed to its stock rising, with shares showing progress. The news highlights Amgen's promising developments in the medical field.

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [Amgen’s dazodalibep reduces Sjögren’s disease activity in Phase 3 trial](https://longbridge.com/en/news/305170465.md)
- [REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY | AMGN Stock News](https://longbridge.com/en/news/304469501.md)
- [Amgen Inc. $AMGN Shares Acquired by VestGen Advisors LLC](https://longbridge.com/en/news/303720186.md)
- [How Phase 3 Sjögren’s Results At Amgen (AMGN) Has Changed Its Investment Story](https://longbridge.com/en/news/300175029.md)
- [Berkshire Hathaway (BRK.A) Stock May Trade At A Discount On Record Buybacks](https://longbridge.com/en/news/305497305.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**